Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cholesterol Palmitate
2. 601-34-3
3. Cholesteryl Hexadecanoate
4. Hexadecanoic Acid, Cholesteryl Ester
5. Cholesterol, Palmitate
6. Cholest-5-en-3-ol (3.beta.)-, Hexadecanoate
7. 16:0 Cholesteryl Ester
8. Ce(16:0)
9. Cholest-5-ene-3-beta-yl Palmitate
10. 16:0 Cholesterol Ester
11. Cholest-5-en-3beta-yl Hexadecanoate
12. Palmitic Acid Cholesteryl Ester
13. Zr4d53ad57
14. Nsc-59692
15. (3beta)-cholest-5-en-3-ol Hexadecanoate
16. (3beta)-cholest-5-en-3-yl Hexadecanoate
17. 5-cholestene 3-palmitate
18. Cholest-5-en-3-ol (3beta)-, 3-hexadecanoate
19. (3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-((r)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl Palmitate
20. Cholesterol Hexadecanoate
21. Unii-zr4d53ad57
22. Einecs 210-002-5
23. Mfcd00003638
24. Nsc 59692
25. 1-palmitoyl-cholesterol
26. Cholesterol 1-palmitoate
27. Cholesteryl 1-palmitoate
28. Cholesteryl Palmitic Acid
29. Bmse000544
30. Cholesterol 1-hexadecanoate
31. Cholesteryl 1-hexadecanoate
32. Cholesterol Ester(16:0)
33. Cholesterol 1-palmitoic Acid
34. Cholesteryl 1-palmitoic Acid
35. Cholesteryl Hexadecanoic Acid
36. Cholesteryl Palmitate, 97%
37. Cholest-5-en-3-yl Palmitate
38. Schembl295637
39. Chebi:3663
40. Cholesterol 1-hexadecanoic Acid
41. Cholesteryl 1-hexadecanoic Acid
42. Palmitic Acid Cholesterol Ester
43. Cholesterol Palmitate, >/=97%
44. Dtxsid40889356
45. Cholesterol Ester(16:0/0:0)
46. Hexadecanoic Acid Cholesteryl Ester
47. Nsc59692
48. Zinc8234393
49. Lmst01020005
50. 3.beta.-hexadecanoyloxycholest-5-ene
51. Akos015839810
52. Akos015915569
53. (3beta)-cholest-5-en-3-yl Palmitate
54. Cs-w011424
55. Ds-4666
56. Hy-w010708
57. [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] Hexadecanoate
58. 16:0(ce)
59. Cholest-5-en-3-ol (3beta)-, Hexadecanoate
60. D95354
61. Op0201 Component Cholesteryl Palmitate
62. Cholest-5-en-3-ol (3.beta.)-, 3-hexadecanoate
63. W-105278
64. Q27068156
65. Cholesteryl Palmitate, >=98% (hplc; Detection At 205 Nm)
66. (3s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-((r)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl Palmitate
Molecular Weight | 625.1 g/mol |
---|---|
Molecular Formula | C43H76O2 |
XLogP3 | 16.4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 21 |
Exact Mass | 624.58453166 g/mol |
Monoisotopic Mass | 624.58453166 g/mol |
Topological Polar Surface Area | 26.3 Ų |
Heavy Atom Count | 45 |
Formal Charge | 0 |
Complexity | 904 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Cholesteryl Palmitate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cholesteryl Palmitate, including repackagers and relabelers. The FDA regulates Cholesteryl Palmitate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cholesteryl Palmitate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cholesteryl Palmitate supplier is an individual or a company that provides Cholesteryl Palmitate active pharmaceutical ingredient (API) or Cholesteryl Palmitate finished formulations upon request. The Cholesteryl Palmitate suppliers may include Cholesteryl Palmitate API manufacturers, exporters, distributors and traders.
click here to find a list of Cholesteryl Palmitate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cholesteryl Palmitate DMF (Drug Master File) is a document detailing the whole manufacturing process of Cholesteryl Palmitate active pharmaceutical ingredient (API) in detail. Different forms of Cholesteryl Palmitate DMFs exist exist since differing nations have different regulations, such as Cholesteryl Palmitate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cholesteryl Palmitate DMF submitted to regulatory agencies in the US is known as a USDMF. Cholesteryl Palmitate USDMF includes data on Cholesteryl Palmitate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cholesteryl Palmitate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cholesteryl Palmitate suppliers with USDMF on PharmaCompass.
Cholesteryl Palmitate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cholesteryl Palmitate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cholesteryl Palmitate GMP manufacturer or Cholesteryl Palmitate GMP API supplier for your needs.
A Cholesteryl Palmitate CoA (Certificate of Analysis) is a formal document that attests to Cholesteryl Palmitate's compliance with Cholesteryl Palmitate specifications and serves as a tool for batch-level quality control.
Cholesteryl Palmitate CoA mostly includes findings from lab analyses of a specific batch. For each Cholesteryl Palmitate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cholesteryl Palmitate may be tested according to a variety of international standards, such as European Pharmacopoeia (Cholesteryl Palmitate EP), Cholesteryl Palmitate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cholesteryl Palmitate USP).
LOOKING FOR A SUPPLIER?